ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 579

MRI-Detected Osteitis Is Not Associated with the Presence or Level of ACPA Alone, but with the Combined Presence of ACPA and RF

Debbie M. Boeters1, Wouter P. Nieuwenhuis1, Marije K. Verheul1, Elize C. Newsum1, Monique Reijnierse2, René E.M. Toes1, Leendert A. Trouw1 and Annette H.M. van der Helm-van Mil1, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Radiology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: anti-citrullinated protein/peptide antibodies (ACPA), bone marrow lesions and rheumatoid arthritis (RA), MRI, Rheumatoid Factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Within rheumatoid arthritis (RA) bone marrow edema (BME, osteitis) and anti-citrullinated protein antibodies (ACPAs) are associated with radiographic progression. ACPA has been associated with BME, but it is unknown if this association is confined to ACPA and BME. We cross-sectionally studied the association of ACPA, rheumatoid factor (RF) and anti-carbamylated protein (anti-CarP) antibodies with BME and other types of MRI-detected inflammation (synovitis, tenosynovitis).

Methods:  589 DMARD-naïve early arthritis patients, included in the Leiden Early Arthritis Clinic, underwent contrast-enhanced 1.5T MRI of unilateral wrist, metacarpophalangeal and metatarsophalangeal-joints at baseline. BME, synovitis and tenosynovitis were scored by two readers. ACPA, RF and anti-CarP were determined at baseline.

Results:  In univariable analyses ACPA-positive patients had higher BME-scores than ACPA-negative patients (median 4.5 vs. 2.0, p<0.001), but not more synovitis and tenosynovitis. Also RF (median 3.75 vs. 2.0, p<0.001) and anti-CarP antibodies (median 3.5 vs. 2.5, p=0.012) were associated with higher BME-scores. Because the autoantibodies were concomitantly present, analyses were stratified for the presence of different autoantibody combinations. ACPA+RF-anti-CarP- patients did not have higher BME-scores than ACPA-RF-anti-CarP- patients. However ACPA+RF+anti-CarP- and ACPA+RF+anti-CarP+ patients had higher BME-scores than ACPA-RF-anti-CarP- patients (median 5.0 and 4.5 vs. 2.0, p<0.001 and p<0.001). ACPA levels were not associated with BME-scores. Analyses within RA- and UA-patients revealed similar results.

Conclusion:  The single presence of ACPA and ACPA-level were not statistically significant associated with BME-scores, but the combined presence of ACPA and RF did associate with more BME. This suggests an additive role of RF to ACPA in mediating osteitis.


Disclosure: D. M. Boeters, None; W. P. Nieuwenhuis, None; M. K. Verheul, None; E. C. Newsum, None; M. Reijnierse, None; R. E. M. Toes, None; L. A. Trouw, None; A. H. M. van der Helm-van Mil, None.

To cite this abstract in AMA style:

Boeters DM, Nieuwenhuis WP, Verheul MK, Newsum EC, Reijnierse M, Toes REM, Trouw LA, van der Helm-van Mil AHM. MRI-Detected Osteitis Is Not Associated with the Presence or Level of ACPA Alone, but with the Combined Presence of ACPA and RF [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/mri-detected-osteitis-is-not-associated-with-the-presence-or-level-of-acpa-alone-but-with-the-combined-presence-of-acpa-and-rf/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mri-detected-osteitis-is-not-associated-with-the-presence-or-level-of-acpa-alone-but-with-the-combined-presence-of-acpa-and-rf/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology